Identification of an epidemic carbapenem-resistant Acinetobacter baumannii strain at hospitals in Buenos Aires City

Diagnostic Microbiology and Infectious Disease

Volumn 45, Issue 4, 2003, Pages 261-264

  Barbolla, Raquel Eve ^a   Centrón, Daniela ^a   Di Martino, Ana ^b   Maimone, Stella ^b   Salgueira, Claudia ^b   Famiglietti, Angela ^a   Vay, Carlos ^a   Catalano, Mariana ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b Sanatorio Mitre   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIINFECTIVE AGENT; CARBAPENEM; CEFOPERAZONE; CEFTAZIDIME; CEPHOPERAZONE PLUS SUBLACTAM; CIPROFLOXACIN; COLISTIN; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; SULBACTAM; SULTAMICILLIN; TAZOBACTAM; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ARGENTINA; ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CLONE; CONTROLLED STUDY; EPIDEMIC; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RESTRICTION MAPPING;

EID: 0038702320     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(02)00538-2     Document Type: Article

References (17)

1. Afzal-Shah M., Woodford N., Livermore D.M. Characterization of OXA-25, OXA-26, and OXA-27, molecular class D β-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii. Antimicrob Agent Chemother. 45:2001;583-588.
2. Bouvet P.J.M., Jeanjean S. Delineation of new proteolytic genomic species in the genus Acinetobacter. Res Microbiol. 140:1989;291-299.
3. Corbella X., Montero A., Pujol M., Domínguez M.A., Ayats J., Argerich M.J., Garrigosa F., Ariza J., Gudiol F. Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii. J Clin Microbiol. 38:2000;4086-4095.
4. Da Silva Coimbra M.V., Teixera L.A., Ramos R.L., Predari S.C., Castello L., Famiglietti A., Vay C., Klan L., Figueiredo A.M. Spread of the Brazilian epidemic clone of multiresistant MRSA in two cities in Argentina. J Med Microbiol. 49:2000;187-192.
5. Go E.S., Urban C., Burns J., Kreiswirth B., Eisner W., Mariano N., Mosinka-Snipas K., Rahal J.J. Clinical and molecular epidemiology of Acinetobacter infections sensitive to polymyxin B and sulbactam. Lancet. 350:1994;1329-1332.
6. Gales A., Reis A.O., Jones R.N. Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin Review of available interpretative criteria and quality control guidelines . J Clin Microbiol. 39:2001;183-190.
7. Gerner-Smidt P., Tjernberg I., Ursing J. Reliability of phenotypic tests for identification of Acinetobacter species. J Clin Microbiol. 29:1991;277-282.
8. Gerner-Smidt P. Ribotyping of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex. J Clin Microbiol. 30:1992;2680-2685.
9. Jawad A., Heritage J., Snelling A.M., Gascoyne-Binzi D.M., Hawkey P.M. Influence of relative humidity and suspending menstrua on survival of Acinetobacter spp. on dry surfaces. J Clin Microbiol. 34:1996;2881-2887.
10. Koeleman J.G.M., Stoof J., van der Bijl M.W., Vandenbroucke-Grauls C.M.J.E., Savelkoul P.H.M. Identification of epidemic strains of Acinetobacter baumannii by integrase gene polymerase chain reaction. J Clin Microbiol. 39:2001;8-13.
11. Koeleman J.G.M., van der Bijl M.W., Stoof J., Vandenbroucke-Grauls C.M.J.E., Savelkoul P.H.M. Antibiotic resistance is a major risk factor for epidemic behavior of Acinetobacter baumannii. Infect Control Hosp Epidemiol. 22:2001;284-288.
12. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. M100-S11, vol 21, N° 1. National Committee for Clinical Laboratory Standards, Wayne, PA 2001.
13. Quelle L.S., Catalano M. Efficacy of two DNA fingerprinting methods for typing Acinetobacter baumannii isolates. Diag Microbiol Inf Dis. 39:2001;215-223.
14. Levin A.S., Barone A.A., Penco J., Santos M.V., Marinho I.S., Arruda E.A., Manrique E.I., Costa S.F. Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. Clin Infect Dis. 28:1999;1008-1011.
15. Paavilainen T., Alanen M., Makela M., Routamaa M., Jarvinen H., Huovinen P., Kotilainen P. Infrequent isolation of multiresistant Acinetobacter baumannii from the staff tending a colonized patient with severe burns. Infect Control Hosp Epidemiol. 22:2001;388-391.
16. Struelens M.J. Consensus guidelines for appropriate use and evaluation of microbial epidemiologic typing systems. Clin Microbiol Infect. 2:1996;2-11.
17. Takahashi A., Yomoda S., Kobayashi I., Okubo T., Tsunoda M., Iyobe S. Detection of carbapenemase-producing Acinetobacter bauamnnii in a hospital. J Clin Microbiol. 38:2000;526-529.